Taking advantage of central role of GCK in glucose homeostasis, its activators – which are able to bind to the allosteric site, change kinetic parameters of GCK, and render the molecule more sensitive to glucose – have gained a lot of attention for better management of Type 2 Diabetes Mellitus (T2DM). This evidence concerns the gene GCK and diabetes mellitus.